Episode 518: Journal Club of 2nd-Gen Anti-VEGF Drugs, Povidone Iodine during Vitrectomy for Endophthalmitis, Racial and Ethnic Disparities in Retinal Disease, and Pegcetacoplan for Geographic Atrophy
Straight From The Cutter's Mouth: A Retina PodcastShow Notes
Drs. Katherine Talcott, Akshay Thomas, and Sarwar Zahid join to discuss four recent publications in major ophthalmology journals:
Real-World Outcomes with Second Generation Injected Anti-VEGF Drugs (https://pubmed.ncbi.nlm.nih.gov/42717802/) Povidone Iodine during Vitrectomy for Endophthalmitis (https://www.ovid.com/jnls/retinajournal/abstract/10.1097/iae.0000000000005006~adjunct-0025-povidone-iodine-irrigation-at-time-of?redirectionsource=fulltextview) Racial and Ethnic Disparities in Retinal Disease (https://www.aaojournal.org/article/S0161-6420(26)00648-2/abstract) Two-Year Real-World Outcomes of Pegcetacoplan for Geographic Atrophy (https://pubmed.ncbi.nlm.nih.gov/42727684/)
This episode was sponsored by Cited. Cited is PubMed meets Instagram Stories for retina specialists, free to download, made for hearing what your peers think about the latest research. Find it at https://apps.apple.com/us/app/cited-for-retina/id6764145960.
More from Straight From The Cutter's Mouth: A Retina Podcast
Dr. Frank Brodie joins to discuss device design as a retina specialist including his innovative intraocular lens implantable scaffold that is currently in trial and the PRIMA subretinal prosthesis.
Disclosures: This episode was sponsored by Cited. Cited is PubMed meets Instagram Stories for retina specialists, free to download, made for hearing what your peers think about the latest research. Find it at https://apps.apple.com/us/app/cited-for-retina/id6764145960.
Dr. Camille Palma joins to discuss several topics including mentorship in the retina space and career progression and development.
Drs. Maura Di Nicola and Basil Williams join to discuss the September 2026 edition of Retinal Physician found online at http://www.retinalphysician.com. Topics focus on ocular oncology and uveitis.
Drs. Mohsin Ali and Katherine Talcott join to discuss the LUGANO Phase 3 Trial results, which examined vorolanib in the treatment of wet age-related macular degeneration.